Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Koelewijn

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Vox Sanguinis|April 23, 2015
Haemolytic disease of the fetus and newbornM de Haas, F F Thurik, J M Koelewijn, et al.
Transfusion|February 6, 2008
Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the NetherlandsJ M Koelewijn, T G M Vrijkotte, C E van der Schoot, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|June 23, 2009
Risk factors for RhD immunisation despite antenatal and postnatal anti-D prophylaxisJ M Koelewijn, M de Haas, T G M Vrijkotte, et al.
BMC Pregnancy and Childbirth|November 19, 2008
Women's attitude towards prenatal screening for red blood cell antibodies, other than RhDJ M Koelewijn, T G M Vrijkotte, M de Haas, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|February 13, 2009
Risk factors for the presence of non-rhesus D red blood cell antibodies in pregnancyJ M Koelewijn, T G M Vrijkotte, M de Haas, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|December 15, 2015
Third trimester screening for alloimmunisation in Rhc-negative pregnant women: evaluation of the Dutch national screening programmeY M Slootweg, J M Koelewijn, I L van Kamp, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|February 8, 2022
Risk factors for RhD immunisation in a high coverage prevention programme of antenatal and postnatal RhIg: a nationwide cohort studyY M Slootweg, C Zwiers, J M Koelewijn, et al.
Nederlands Tijdschrift Voor Geneeskunde|August 12, 2020
[Revised multidisciplinary guidelines 'Varicella'; broader indication for post-exposure prophylaxis]J J A van Kampen, A H W Bruns, E van Leeuwen, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Vox Sanguinis|April 23, 2015
Haemolytic disease of the fetus and newbornM de Haas, F F Thurik, J M Koelewijn, et al.
Transfusion|February 6, 2008
Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the NetherlandsJ M Koelewijn, T G M Vrijkotte, C E van der Schoot, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|June 23, 2009
Risk factors for RhD immunisation despite antenatal and postnatal anti-D prophylaxisJ M Koelewijn, M de Haas, T G M Vrijkotte, et al.
BMC Pregnancy and Childbirth|November 19, 2008
Women's attitude towards prenatal screening for red blood cell antibodies, other than RhDJ M Koelewijn, T G M Vrijkotte, M de Haas, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|February 13, 2009
Risk factors for the presence of non-rhesus D red blood cell antibodies in pregnancyJ M Koelewijn, T G M Vrijkotte, M de Haas, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|December 15, 2015
Third trimester screening for alloimmunisation in Rhc-negative pregnant women: evaluation of the Dutch national screening programmeY M Slootweg, J M Koelewijn, I L van Kamp, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|February 8, 2022
Risk factors for RhD immunisation in a high coverage prevention programme of antenatal and postnatal RhIg: a nationwide cohort studyY M Slootweg, C Zwiers, J M Koelewijn, et al.
Nederlands Tijdschrift Voor Geneeskunde|August 12, 2020
[Revised multidisciplinary guidelines 'Varicella'; broader indication for post-exposure prophylaxis]J J A van Kampen, A H W Bruns, E van Leeuwen, et al.
Pageof 1